Advanced Chemotherapy Technologies, Inc. is a privately owned, clinical-stage company developing novel approaches to local drug delivery. Its lead product is the first-in-class to combine iontophoresis drug delivery with an implantable delivery system to target drug delivery with laser-like precision. Advanced Chemotherapy Technologies drug delivery technology was first developed at and licensed from the University of North Carolina at Chapel Hill in conjunction with UNC Lineberger Comprehensive Cancer Center.
AliveCor has a device and application that will turn any smartphone into a clinical-quality electrocardiogram (ECG) recorder. The company is dedicated to enabling users to take control of their heart health.
Apton Biosystems, Inc. operates in the healthcare industry focusing on biotechnology business.
Arpeggio is building a platform to explore biology’s regulatory network.
BIOAGE discovers and develops proprietary drugs to treat aging and associated diseases.
Bold’s digital platform uses personalized exercise programs to address some of the most fundamental health and wellbeing challenges faced by older adults. Bold leverages research and data science to prevent falls, manage chronic conditions, and increase activity levels for older adults with clinically-effective and engaging exercise programs. Bold partners with health plans and providers to improve member outcomes and reduce care costs.
Caption Health was founded in 2013 on a simple but powerful concept: what if we could use technology to emulate the expertise of highly trained medical experts and put that ability into the hands of every care provider? Our vision is to move specialty diagnostics and decision making to the point of care for every patient exam. We are developing AI software that empowers healthcare providers with new capabilities to acquire and interpret ultrasound exams.
The CareSwitch platform helps home care agencies manage payroll, benefits, and employee records to comply with changes in employment laws.
Carrot is using technology and evidence-based strategies to engage and empower millions of people to quit smoking.
Cellino is engineering human-like cells and tissues for replacement therapies.